iSMAR: Natural History of SMA

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Recruiting
CT.gov ID
NCT05755451
Collaborator
University of Milan (Other), Istituto Giannina Gaslini (Other), Ospedale Pediatrico Bambin Gesù (Other), University of Messina (Other)
1,200
5
186.3
240
1.3

Study Details

Study Description

Brief Summary

This is an investigator initiated observational study with the aim to record several aspects of function, care and adverse events in a large cohort of SMA patients followed longitudinally by using a structured academic disease registry.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is an observational multicenter retrospective and prospective study involving high quality data collected in 5 academic centers in Italy, the registry aims to

    • better understand the natural history of the disease in untreated patients identifying factors that can influence disease progression by combining retrospective and prospective data.

    • Describe the patterns of disease progression (in terms of functional measure, adverse events, levels of care, and hospitalization) in treated and untreated patients

    • Identify all the patients treated with the available therapies in Italy, providing first line details on epidemiological data in a wider network including all centers recognized as centers for spinal muscular atrophy (SMA) in each region.

    As part of the activity clinical evaluators, data manager and sub-investigators are also trained and use common manuals of operation to ensure reliability across the participating centers. The registry provides accurate and reliable information on natural history including results from currently used functional measures. The registry also includes information on supportive care, hospitalization and adverse events.

    Details of the electronic clinical file record including data assembly and the platform used are available as part of a peer reviewed paper

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    1200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Natural History of SMA: Long Term Longitudinal Study and Development of a Registry
    Actual Study Start Date :
    Jun 21, 2018
    Anticipated Primary Completion Date :
    Dec 30, 2033
    Anticipated Study Completion Date :
    Dec 30, 2033

    Outcome Measures

    Primary Outcome Measures

    1. motor function [15 years]

      functional scales Hammersmith Functional motor scale, (minimum score 0, maximum score 74 indicating best performance

    Secondary Outcome Measures

    1. respiratory function [15 years]

      Forced Vital Capacity, need for ventilatory support

    2. nutrition [15 years]

      need for nutritional support using Oral and Swallowing Abilities Tool (OrSAT) with a minimum score of 0 and a maximum score of 12 indicating best performance

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    all patients

    Exclusion Criteria:

    if enrolled in clinical trials

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Istituto Gaslini Genova Italy
    2 Nemo Sud Messina Italy
    3 Centro Clinico nemo Milano Italy
    4 Ospedale Bambino gesu Rome Italy
    5 Policlinico gemelli Rome Italy

    Sponsors and Collaborators

    • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    • University of Milan
    • Istituto Giannina Gaslini
    • Ospedale Pediatrico Bambin Gesù
    • University of Messina

    Investigators

    • Principal Investigator: Eugenio Mercuri, MD, F Policlinico Gemelli IRCCS

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    ClinicalTrials.gov Identifier:
    NCT05755451
    Other Study ID Numbers:
    • 1894
    First Posted:
    Mar 6, 2023
    Last Update Posted:
    Mar 6, 2023
    Last Verified:
    Feb 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 6, 2023